Jul 14
|
Ferrara holding company in talks to buy French confectioner CPK
|
Jul 11
|
Ferrara's Holding Company Enters into Exclusive Discussions to Acquire CPK Group
|
Jul 10
|
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
|
Jul 10
|
NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
|